Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kromek Group plc ( (GB:KMK) ) has shared an announcement.
Kromek Group plc has announced that it will release its interim results for the six months ending 31 October 2025 on 20 January 2026. The company will host an online Q&A session for investors on 26 January 2026, providing an opportunity for stakeholders to engage with the CEO and CFO. This announcement underscores Kromek’s commitment to transparency and stakeholder engagement, potentially impacting investor confidence and market positioning.
The most recent analyst rating on (GB:KMK) stock is a Buy with a £7.00 price target. To see the full list of analyst forecasts on Kromek Group plc stock, see the GB:KMK Stock Forecast page.
Spark’s Take on GB:KMK Stock
According to Spark, TipRanks’ AI Analyst, GB:KMK is a Outperform.
Kromek Group plc’s overall stock score of 72 reflects its strong financial performance and positive corporate events, which are the most significant factors. The technical analysis presents a mixed picture, while the valuation suggests potential undervaluation. The absence of earnings call data does not impact the score significantly.
To see Spark’s full report on GB:KMK stock, click here.
More about Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions, focusing on advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, with manufacturing operations in the UK and US, Kromek aims to enhance quality of life through innovative detection technology. The company serves medical, security, and industrial markets with its cadmium zinc telluride (CZT) platform, providing solutions for disease detection, industrial contamination, and aviation security. In CBRN detection, Kromek offers nuclear radiation detection solutions for homeland defense and security, and is developing bio-security solutions for airborne pathogen detection.
Average Trading Volume: 2,085,651
Technical Sentiment Signal: Buy
Current Market Cap: £50.44M
For an in-depth examination of KMK stock, go to TipRanks’ Overview page.